Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: Implications for clinical practice

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 5, 2015, Pages 715-722

  Fahim, Magid A ^a,b   Hayen, Andrew D ^c   Horvath, Andrea R ^d,e,f   Dimeski, Goce ^a,b   Coburn, Amanda ^a   Tan, Ken Soon ^g   Johnson, David W ^a,b   Craig, Jonathan C ^e,h   Campbell, Scott B ^a,b   Hawley, Carmel M ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g Logan Hospital   (Australia)

^h CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

renal dialysis; troponin T; variability

Indexed keywords

TROPONIN T;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART MUSCLE INJURY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MIDDLE AGED; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT; ACUTE DISEASE; EARLY DIAGNOSIS; KIDNEY FUNCTION TEST; METABOLISM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY;

ACUTE DISEASE; AGED; EARLY DIAGNOSIS; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERITONEAL DIALYSIS; SENSITIVITY AND SPECIFICITY; TROPONIN T;

EID: 84928010996     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0838     Document Type: Article

References (36)

1. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 2004;65:2380-9.
2. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238-48.
3. US Renal Data System. USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases: Bethseda, MD, 2012.
4. McDonald SP, Tong B. Morbidity burden of end-stage kidney disease in Australia: hospital separation rates among people receiving kidney replacement therapy. Nephrology (Carlton) 2011;16:758-66.
5. Sacchetti A, Harris R, Patel K, Attewell R. Emergency department presentation of renal dialysis patients: indications for EMS transport directly to dialysis centers. J Emerg Med 1991;9:141-4.
6. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation 2012;126:2020-35.
7. Group NW, Wu AH, Jaffe AS, Apple FS, Jesse RL, Francis GL, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007;53:2086-96.
8. Jaffe AS, Apple FS. The third universal definition of myocardial infarction - moving forward. Clin Chem 2012;58:1727-8.
9. Fraser C. The nature of biological variation. In: Fraser C, Biological variation: from principles to practice. Washington, DC: AACC Press, 2001:1-27.
10. Astion ML, Shojania KG, Hamill TR, Kim S, Ng VL. Classifying laboratory incident reports to identify problems that jeopardize patient safety. Am J Clin Pathol 2003;120:18-26.
11. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011;412:748-54.
12. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
13. Park J, Chung HC, Kim MS, Kim SJ, Chang JW, Lee JS. Relationship between extracellular water fraction of total body water estimated by bioimpedance spectroscopy and cardiac troponin T in chronic haemodialysis patients. Blood Purif 2009;28:61-8.
14. Turer AT, Addo TA, Martin JL, Sabatine MS, Lewis GD, Gerszten RE, et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. J Am Coll Cardiol 2011;57:2398-405.
15. Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010;56:642-50.
16. Pianta TJ, Horvath AR, Ellis VM, Leonetti R, Moffat C, Josland EA, et al. Cardiac high-sensitivity troponin T measurement: a layer of complexity in managing haemodialysis patients. Nephrology (Carlton) 2012;17:636-41.
17. Lippi G, Tessitore N, Montagnana M, Salvagno GL, Lupo A, Guidi GC. Influence of sampling time and ultrafiltration coefficient of the dialysis membrane on cardiac troponin I and T. Arch Pathol Lab Med 2008;132:72-6.
18. Campeau L. Letter: grading of angina pectoris. Circulation 1976;54:522-3.
19. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22(4 Suppl A):6A-13A.
20. Moissl UM, Wabel P, Chamney PW, Bosaeus I, Levin NW, Bosy-Westphal A, et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiological measurement 2006;27:921-33.
21. Kraemer M, Rode C, Wizemann V. Detection limit of methods to assess fluid status changes in dialysis patients. Kidney Int 2006;69:1609-20.
22. th percentile cardiac troponin T concentrations measured with a high-sensitivity assay. Clin Chem 2013;59:442-3.
23. Roraas T, Petersen PH, Sandberg S. Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals. Clin Chem 2012;58:1306-13.
24. Redfield MM, Jacobsen SJ, Burnett JC, Jr., Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. J Am Med Assoc 2003;289:194-202.
25. Fokkema MR, Herrmann Z, Muskiet FA, Moecks J. Reference change values for brain natriuretic peptides revisited. Clin Chem 2006;52:1602-3.
26. Iglesias N, Petersen PH, Ricos C. Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality. Clin Chem Lab Med 2005;43:441-8.
27. Pretorius CJ, Wilgen U, Ungerer JP. Serial cardiac troponin differences measured on four contemporary analyzers: relative differences, actual differences and reference change values compared. Clin Chim Acta 2012;413:1786-91.
28. Ie EH, Klootwijk PJ, Weimar W, Zietse R. Significance of acute versus chronic troponin T elevation in dialysis patients. Nephron Clin Pract 2004;98:c87-92.
29. Hill SA, Cleve R, Carlisle E, Young E, McQueen MJ. Intra-individual variability in troponin T concentration in dialysis patients. Clin Biochem 2009;42:991-5.
30. Frankenstein L, Wu AH, Hallermayer K, Wians FH, Jr., Giannitsis E, Katus HA. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem 2011;57:1068-71.
31. Nordenskjold AM, Ahlstrom H, Eggers KM, Frobert O, Jaffe AS, Venge P, et al. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem 2013;59:401-9.
32. Aakre KM, Roraas T, Petersen PH, Svarstad E, Sellevoll H, Skadberg O, et al. Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clin Chem 2014;60:838-47.
33. Jacobs LH, van de Kerkhof J, Mingels AM, Kleijnen VW, van der Sande FM, Wodzig WK, et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009;46:283-90.
34. Jefferies HJ, Virk B, Schiller B, Moran J, McIntyre CW. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 2011;6:1326-32.
35. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009;20:155-63.
36. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. J Am Med Assoc 2001;286:2405-12.